West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8568-8575

  Brien, James D ^a,c   Uhrlaub, Jennifer L ^a,b   Nikolich Zǔgich, Janko ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; NONSTRUCTURAL PROTEIN 3; PEPTIDE DERIVATIVE; SUBUNIT VACCINE; WEST NILE VACCINE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; IMMUNOCOMPETENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS IMMUNITY; WEST NILE FLAVIVIRUS; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL LINE; CYTOTOXICITY TEST; IMMUNOLOGY; MOLECULAR GENETICS; MORTALITY; MOUSE MUTANT; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; SECRETION; TRANSPLANTATION; VIROLOGY; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; IMMUNODOMINANT EPITOPES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; VACCINES, SUBUNIT; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 58849165766     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8568     Document Type: Article

References (38)

1. Anderson, J. F., T. G. Andreadis, C. R. Vossbrinck, S. Tirrell, E. M. Wakem, R. A. French, A. E. Garmendia, and H. J. Van Kruiningen. 1999. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 286: 2331-2333.
2. Lanciotti, R. S., J. T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, B. Crise, K. E. Volpe, M. B. Crabtree, J. H. Scherret, et al. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333-2337.
3. Centers for Disease Control and Prevention. 2006. West Nile virus activity: United States, January 1-November 7, 2006. Morbid. Mortal. Wkly. Rep. 55: 1204-1205.
4. Petersen, L. R., A. A. Marfin, and D. J. Gubler. 2003. West Nile virus. J. Am. Med. Assoc. 290: 524-528.
5. Centers for Disease Control and Prevention. 2008. West Nile virus update, United States, January 1-August 19, 2008. Morbid. Mortal. Wkly. Rep. 57: 899-901.
6. Marfin, A. A., L. R. Petersen, M. Eidson, J. Miller, J. Hadler, C. Farello, B. Werner, G. L. Campbell, M. Layton, P. Smith, et al. 2001. Widespread West Nile virus activity, eastern United States, 2000. Emerg. Infect. Dis. 7: 730-735.
7. Chambers, T. J., and M. S. Diamond. 2003. Pathogenesis of flavivirus encephalitis. Adv. Virus Res. 60: 273-342.
8. Hayes, C. 2001. West Nile virus: Uganda. Ann. NY Acad. Sci. 951: 25.
9. Diamond, M. S., B. Shrestha, E. Mehlhop, E. Sitati, and M. Engle. 2003. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16: 259-278.
10. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79: 11457-11466.
11. Kulkarni, A. B., A. Mullbacher, C. R. Parrish, E. G. Westaway, G. Coia, and R. V. Blanden. 1992. Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression. J. Virol. 66: 3583-3592.
12. Shresta, S., J. L. Kyle, H. M. Snider, M. Basavapatna, P. R. Beatty, and E. Harris. 2004. Interferon-dependent immunity is essential for resistance to primary Dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 78: 2701-2710.
13. + T cells in control of West Nile virus infection. J. Virol. 78: 8312-8321.
14. + T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80: 12060-12069.
15. + T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 37: 1855-1863.
16. Purtha, W. E., N. Myers, V. Mitaksov, E. Sitati, J. Connolly, D. H. Fremont, T. H. Hansen, and M. S. Diamond. 2007. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 37: 1845-1854.
17. + T cells. J. Gen. Virol. 77: 705-714.
18. Liu, T., and T. J. Chambers. 2001. Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and γ interferon- deficient mice and requirement for CD4+ lymphocytes. J. Virol. 75: 2107-2118. (Pubitemid 32147550)
19. + T cells in protective immunity to influenza. Immunol. Rev. 211: 8-22.
20. Brown, D. M., A. M. Dilzer, D. L. Meents, and S. L. Swain. 2006. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol. 177: 2888-2898.
21. Tishon, A., H. Lewicki, A. Andaya, D. McGavern, L. Martin, and M. B. Oldstone. 2006. CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. Virology 347: 234-245.
22. + T cells in the prevention of measles virus-induced encephalitis in mice. J. Gen. Virol. 81: 2707-2713.
23. Nybakken, G. E., T. Oliphant, S. Johnson, S. Burke, M. S. Diamond, and D. H. Fremont. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437: 764-769.
24. Jellison, E. R., S. K. Kim, and R. M. Welsh. 2005. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol. 174: 614-618.
25. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan, and M. Engle. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77: 2578-2586.
26. + T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80: 119-129.
27. + T cells into the brain and protection against West Nile Virus encephalitis. J. Virol.
28. + T cells during primary pulmonary influenza virus infection. J. Immunol. 174: 5332-5340.
29. Dyall, R., L. V. Vasovic, A. Molano, and J. Nikolic-Zugic. 1995. CD4-independent in vivo priming of murine CTLs by optimal MHC class I-restricted peptides derived from HIV and other pathogens. Int. Immunol. 7: 1205-1212.
30. Mathur, A., K. L. Arora, and U. C. Chaturvedi. 1983. Host defense mechanisms against Japanese encephalitis virus infection in mice. J. Gen. Virol. 64: 805-811. (Pubitemid 13163218)
31. + T-lymphocyte responses in a recipient of an experimental live-attenuated Dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. J. Virol. 67: 5962-5967.
32. Kulkarni, A. B., A. Mullbacher, and R. V. Blanden. 1991. Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation. Immunol. Cell Biol. 69: 71-80.
33. + cytotoxic T-cell responses. J. Virol. 75: 11457-11463.
34. Kumar, P., P. Sulochana, G. Nirmala, R. Chandrashekar, M. Haridattatreya, and V. Satchidanandam. 2004. Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. J. Infect. Dis. 189: 880-891.
35. Rottenberg, M., and K. Kristensson. 2002. Effects of interferon-γ on neuronal infections. Viral Immunol. 15: 247-260.
36. Burdeinick-Kerr, R., and D. E. Griffin. 2005. γ Interferon-dependent, noncytolytic clearance of Sindbis virus infection from neurons in vitro. J. Virol. 79: 5374-5385.
37. Neumann, H., H. Schmidt, E. Wilharm, L. Behrens, and H. Wekerle. 1997. Interferon γ gene expression in sensory neurons: evidence for autocrine gene regulation. J. Exp. Med. 186: 2023-2031. (Pubitemid 28013686)
38. Samuel, M. A., K. Whitby, B. C. Keller, A. Marri, W. Barchet, B. R. Williams, R. H. Silverman, M. Gale, Jr., and M. S. Diamond. 2006. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80: 7009-7019.